BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 4661191)

  • 1. [Absence of thymus hormone in the serum of NZB and NZBXNZW mice and patients with systemic lupus erythematosus].
    Bach JF; Dardenne M
    J Urol Nephrol (Paris); 1972 Dec; 78(12):994-7. PubMed ID: 4661191
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies of thymic factors. I. Evaluation of the mouse rosette assay for thymic hormone.
    Gershwin ME; Steinberg AD; Woody JN; Ahmed A
    J Immunol; 1975 Nov; 115(5):1444-8. PubMed ID: 1080782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chromosome aberrations in F1 (NZBxNZW) mice--an experimental model of systemic lupus erythematosus].
    Skazkina OIa; Lil'p IG; Pleskovskaia GN; Tugolukova SS; Korogodina IuV
    Tsitol Genet; 1984; 18(6):458-9. PubMed ID: 6441320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation, biochemical characteristics, and biological activity of a circulating thymic hormone in the mouse and in the human.
    Bach JF; Dardenne M; Pleau JM; Bach MA
    Ann N Y Acad Sci; 1975 Feb; 249():186-210. PubMed ID: 1079427
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of the New Zealand Black contribution to lupus-like renal disease. Multiple genes that operate in a threshold manner.
    Drake CG; Rozzo SJ; Hirschfeld HF; Smarnworawong NP; Palmer E; Kotzin BL
    J Immunol; 1995 Mar; 154(5):2441-7. PubMed ID: 7868910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of a circulating thymic hormone in mouse and in man.
    Bach JF; Dardenne M; Bach MA
    Transplant Proc; 1973 Mar; 5(1):99-104. PubMed ID: 4695962
    [No Abstract]   [Full Text] [Related]  

  • 7. In vivo and in vitro production of anti-histone antibodies in NZB/NZW mice.
    Gioud M; Kotzin BL; Rubin RL; Joslin FG; Tan EM
    J Immunol; 1983 Jul; 131(1):269-74. PubMed ID: 6863918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin and systemic lupus erythematosus.
    McMurray RW
    Ann Med Interne (Paris); 1996; 147(4):253-8. PubMed ID: 8952744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Demonstration of a thymic hormone in serum].
    Dardenne M; Bach JF
    Ann Inst Pasteur (Paris); 1972 Jul; 123(1):134. PubMed ID: 4539277
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic control of the spontaneous activation of CD4+ Th cells in systemic lupus erythematosus-prone (NZB x NZW) F1 mice.
    Fujii T; Iida Y; Yomogida M; Ikeda K; Haga T; Jikumaru Y; Ninami M; Nishimura N; Kodera Y; Inada Y; Shirai T; Hirose S; Nishimura H
    Genes Immun; 2006 Dec; 7(8):647-54. PubMed ID: 17024131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic lupus erythematosus--immunoregulatory therapies.
    Miller ML; Steinberg AD
    Clin Rheum Dis; 1983 Dec; 9(3):617-28. PubMed ID: 6360516
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-nucleosome antibodies and T-cell response in systemic lupus erythematosus.
    Fournel S; Muller S
    Ann Med Interne (Paris); 2002 Dec; 153(8):513-9. PubMed ID: 12610425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum proteins reacting with DNA and DNA-RNA hybrids in New Zealand mice of different ages].
    Poverennyĭ AM; Nasonova VA; Pleskovskaia GN; Bryksina LE; Podgorodnichenko VK
    Dokl Akad Nauk SSSR; 1980; 251(5):1278-80. PubMed ID: 6156065
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of murine lupus disease in (NZBxNZW)F1 mice by sirolimus treatment.
    Ramos-Barrón A; Piñera-Haces C; Gómez-Alamillo C; Santiuste-Torcida I; Ruiz JC; Buelta-Carrillo L; Merino R; de Francisco AL; Arias M
    Lupus; 2007; 16(10):775-81. PubMed ID: 17895299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sophorae radix reduces autoimmune response in NZB/w F1 systemic lupus erythematosus mouse model.
    Ko E; Lee Y; Park N; Cho C; Yim YN; Kim J; Kim YS; Kim D; Shin MK; Hong MC; Bae H
    Lupus; 2007; 16(5):335-41. PubMed ID: 17576735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Circulating polynucleotide and DNA antibody content and the DNase activity of the blood in clinical and experimental lupus nephritis].
    Demin AA; Lapteva GF; Semenova LA; Kovalenko GA
    Urol Nefrol (Mosk); 1980; (6):43-4. PubMed ID: 7445277
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic factors in systemic lupus erythematosus.
    Russell AS
    J Rheumatol; 1981; 8(2):347-8. PubMed ID: 7194917
    [No Abstract]   [Full Text] [Related]  

  • 18. B cell apoptosis accelerates the onset of murine lupus.
    Trébéden-Nègre H; Weill B; Fournier C; Batteux F
    Eur J Immunol; 2003 Jun; 33(6):1603-12. PubMed ID: 12778478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of distinct immune components in the radiation-induced abrogation of systemic lupus erythematosus development in mice.
    e Brito RR; De Lorenzo BH; Xander P; Godoy LC; Lopes JD; da Silva NP; Sampaio SC; Mariano M
    Lupus; 2007; 16(12):947-54. PubMed ID: 18042588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW mice.
    Hughes GC; Martin D; Zhang K; Hudkins KL; Alpers CE; Clark EA; Elkon KB
    Arthritis Rheum; 2009 Jun; 60(6):1775-84. PubMed ID: 19479860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.